Burkitt’s lymphoma arises from:
Burkitt's lymphoma is a type of non-Hodgkin lymphoma. I remember that it's associated with certain cell types. From what I recall, Burkitt's is a B-cell lymphoma. The specific cell of origin might be the germinal center B cells. These cells are involved in antibody production and are found in lymph nodes.
Now, the options would typically include different cell types. For example, options might be T-cells, B-cells, plasma cells, or something else like natural killer cells. The correct answer here is B-cells. So the options would have B-cells as one of the choices.
Why is that the case? Well, Burkitt's lymphoma is characterized by a translocation involving the MYC gene, usually t(8;14), which leads to overexpression of MYC in B-cells. This translocation is specific to this type of lymphoma. The neoplastic cells are typically centroblasts or blastoid cells, which are part of the germinal center B-cell lineage.
The incorrect options would be other cell types. For instance, T-cell lymphomas are different, like T-cell acute lymphoblastic leukemia. Plasma cell neoplasms would be multiple myeloma. Natural killer cells are involved in other types of lymphomas, such as certain T/NK-cell lymphomas. So each of these options would be incorrect because they don't align with the cell of origin for Burkitt's.
The clinical pearl here is to remember that Burkitt's lymphoma is a high-grade B-cell lymphoma with a specific translocation. The key is the MYC gene translocation and the B-cell origin. Students should note that this is distinct from other lymphomas like follicular lymphoma (which is B-cell but has a different translocation, t(14;18)) or T-cell lymphomas. Also, the rapid growth rate and association with EBV in some cases are important points.
Putting this all together, the correct answer is B-cells. The explanation should cover the pathogenesis, cell type, and the translocation involved. The incorrect options should be explained as not being the origin. The clinical pearl emphasizes the key features to remember for exams.
**Core Concept**
Burkitt's lymphoma is an aggressive B-cell non-Hodgkin lymphoma characterized by a chromosomal translocation involving the *MYC* oncogene. It arises from germinal center B-cells, which are central to humoral immunity and antibody production.
**Why the Correct Answer is Right**
Burkitt's lymphoma originates from **B-cells**, specifically germinal center centroblasts. The hallmark pathogenesis involves the t(8;14)(q24;q32) translocation, placing the *MYC* gene under the control of immunoglobulin heavy chain (IgH) promoters, leading to uncontrolled proliferation. This translocation is unique to Burkitt's lymphoma and drives its aggressive clinical course. The neoplastic cells are small, round, and "blastoid" in